Literature DB >> 21227526

Treating diabetes mellitus in Prader-Willi syndrome with Exenatide.

Ian W Seetho1, Gavin Jones, George A Thomson, Devaka J S Fernando.   

Abstract

We report the use of Exenatide, a GLP-1 agonist, in the management of diabetes mellitus in a 19 year-old female with Prader-Willi syndrome. The beneficial effects of Exenatide in weight reduction and appetite suppression provide a promising strategy for the treatment of obesity and diabetes mellitus in Prader-Willi syndrome.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21227526     DOI： 10.1016/j.diabres.2010.12.009

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN： 0168-8227            Impact factor:   5.602


  9 in total

Review 1.  Review of Prader-Willi syndrome: the endocrine approach.

Authors:  Ryan Heksch; Manmohan Kamboj; Kathryn Anglin; Kathryn Obrynba
Journal:  Transl Pediatr       Date:  2017-10

2.  Genetic Counseling for Diabetes Mellitus.

Authors:  Stephanie A Stein; Kristin L Maloney; Toni I Pollin
Journal:  Curr Genet Med Rep       Date:  2014-06-01

Review 3.  Update on Diabetes Mellitus and Glucose Metabolism Alterations in Prader-Willi Syndrome.

Authors:  Antonino Crinò; Graziano Grugni
Journal:  Curr Diab Rep       Date:  2020-02-06       Impact factor: 4.810

4.  Effects of exenatide on weight and appetite in overweight adolescents and young adults with Prader-Willi syndrome.

Authors:  P Salehi; I Hsu; C G Azen; S D Mittelman; M E Geffner; D Jeandron
Journal:  Pediatr Obes       Date:  2016-04-13       Impact factor: 4.000

Review 5.  Obesity management in Prader-Willi syndrome: current perspectives.

Authors:  Antonino Crinò; Danilo Fintini; Sarah Bocchini; Graziano Grugni
Journal:  Diabetes Metab Syndr Obes       Date:  2018-10-04       Impact factor: 3.168

6.  Successful rapid weight reduction and the use of liraglutide for morbid obesity in adolescent Prader-Willi syndrome.

Authors:  Yoo-Mi Kim; Yeoun Joo Lee; Soo Yeon Kim; Chong Kun Cheon; Han Hyuk Lim
Journal:  Ann Pediatr Endocrinol Metab       Date:  2020-03-31

7.  Intensive management of obesity in people with Prader-Willi syndrome.

Authors:  Brendan J Nolan; Joseph Proietto; Priya Sumithran
Journal:  Endocrine       Date:  2022-05-07       Impact factor: 3.925

8.  The effect of liraglutide on insulin allergy in a patient with glucocorticoid-induced diabetes and multiple sclerosis.

Authors:  Jiudan Zhang; Ye Chen; Jian Wang; Hong Xia; Yang Zheng
Journal:  Nagoya J Med Sci       Date:  2021-05       Impact factor: 1.131

9.  Effectiveness of Sodium-Glucose Cotransporter-2 Inhibitor as an Add-on Drug to GLP-1 Receptor Agonists for Glycemic Control of a Patient with Prader-Willi Syndrome: A Case Report.

Authors:  Yukio Horikawa; Mayumi Enya; Makie Komagata; Ken-Ichi Hashimoto; Masayo Kagami; Maki Fukami; Jun Takeda
Journal:  Diabetes Ther       Date:  2018-01-15       Impact factor: 2.945
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.